Tobira appoints CEO and CFO from Jennerex
This article was originally published in Scrip
Clinical-stage biopharma company Tobira Therapeutics has named its chair, Dr Laurent Fischer, CEO, and has appointed Christopher Peetz CFO. The appointments follow the resignations of former CEO and CFO Andrew Hindman and Carolyn Loewy respectively. Dr Fischer most recently served as chair and CEO of Jennerex, while Mr Peetz also served at Jennerex as vice-president, finance & corporate development.